v3.10.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue
Operating expenses:        
Research and development 1,717,113 717,785 3,804,015 3,144,771
Sales and marketing 109,565 30,198 178,115 77,098
Depreciation and amortization expense 30,028 32,449 90,321 99,048
General and administrative expenses 794,991 720,411 2,078,191 2,264,506
Total operating expenses 2,651,697 1,500,843 6,150,642 5,585,423
Loss from operations (2,651,697) (1,500,843) (6,150,642) (5,585,423)
Other (expense) income:        
Interest expense (327,978) (102,345) (747,492) (183,331)
Other income 1,054 2,082 2,760 3,414
Total other (expense) income (326,924) (100,263) (744,732) (179,917)
Loss before income taxes (2,978,621) (1,601,106) (6,895,374) (5,765,340)
Income tax (expense) benefit
Net loss (2,978,621) (1,601,106) (6,895,374) (5,765,340)
Dividend to series A and B preferred stockholders (320,000) (320,000) (960,000) (960,000)
Net loss attributable to common stockholders $ (3,298,621) $ (1,921,106) $ (7,855,374) $ (6,725,340)
Net loss per common share, basic and diluted (in dollars per share) $ (1.74) $ (1.12) $ (4.23) $ (4.01)
Weighted average number of common shares outstanding, basic and diluted (in shares) 1,898,056 1,720,556 1,855,190 1,677,690

Source